Position in EVGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,537
-$1,258 QoQ
Shares Held
19,404
+52.5% QoQ
Ownership
0.123%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 13 holders
Holding Since
Jun 2021
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EVGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026XTX Topco Ltd holds $413,097,443 across 380 Biotechnology names. EVGN ranks #370 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
30,522 | $19,031,687 | |
| 2 | ASND |
Ascendis Pharma A/S
|
43,289 | $11,546,042 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
116,611 | $8,685,187 | |
| 4 | MRNA |
Moderna, Inc.
|
123,281 | $8,633,368 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
30,496 | $7,348,621 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
|
61,501 | $7,052,319 | |
| 7 | CYTK |
Cytokinetics Inc
|
80,743 | $6,878,496 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
81,923 | $6,682,459 |
All Filings in EVGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,537 | 19,404 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $9,795 | 12,721 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $24,952 | 22,684 | Shares | Defined | 2026-02-17 | |
| 2025-03-31 | $12,723 | 10,179 | Shares | Defined | 2025-05-08 | |
| 2024-06-30 | $9,883 | 15,205 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $8,670 | 11,561 | Shares | Defined | 2024-05-13 | |
| 2021-06-30 | $72,397 | 21,169 | Shares | Defined | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||